THE RELATIONSHIP BETWEEN RISKS OF OBSTRUCTIVE SLEEP APNEA AND DRY EYE DISEASE

Authors

  • Rosy Aldina Department of Ophthalmology, Faculty of Medicine, Universitas Brawijaya, , Dr. Saiful Anwar General Hospital, Malang, Indonesia
  • Ferdian Yanuar Department of Ophthalmology, Faculty of Medicine, Universitas Brawijaya, , Dr. Saiful Anwar General Hospital, Malang, Indonesia
  • Zamroni Afif Department of Neurology, Faculty of Medicine, Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, Indonesia
  • Holipah Department of Public Health Sciences and Preventive Medicine, Universitas Brawijaya, Malang, Indonesia
  • Seskoati Prayitnaningsih Department of Ophthalmology, Faculty of Medicine, Universitas Brawijaya, , Dr. Saiful Anwar General Hospital, Malang, Indonesia

DOI:

https://doi.org/10.21776/ub.mnj.2024.010.02.21

Keywords:

ADDE, Risk of OSA, Metabolic Syndrome, DED Examination

Abstract

Introduction: Dry Eye Disease (DED) may lead to decreased visual function, chronic tissue changes, eyelid, conjunctival, and corneal abnormality. The prevalence of DED in Asia ranges from 21.6%–37.6%. Several studies pointed out the relationship between DED and Obstructive Sleep Apnea (OSA). In patients with OSA, oxidative stress, hypoxia, and ocular surface inflammation increase, leading to a decrease in the functions of meibomian glands, goblet cells, corneal sensitivity, and tear production as a response to the stimulations from the lacrimal glands. The loss of conjunctival goblet cells and meibomian glands are implications of damage to the tear film quality, which results in DED.

 

Method: This is a population-based cross-sectional study. Data were obtained from the database of Biomarker Smarthealth Research in Mendalanwangi, Sidorahayu, and Cepokomulyo Villages, which are located in Malang Regency, having risks of OSA (based on the STOP-BANG questionnaire), above ≥40 years old, and DED Examination with Tear Break-Up Time (TBUT), MGD (Meibominan Gland Dysfunction), Tear Meniscus (TM)  involving a total of 518 respondents. The available data were then processed according to the variables and went through DED examinations. This study employed the purposive sampling method.

 

Result: In this study, moderate risk of OSA suggests a significant influence on the occurrence of DED with an odds ratio (OR) 1.66 (p<0.05). In addition, moderate risk of OSA predisposes ADDE (Aqueous Deficiency Dry Eye)-type and Mix-type DED with OR 2.85 and 1.23 (p<0.05). High risk of OSA correlates with the occurrence of ADDE-type DED with OR 2.37 (p<0.05). The age group >60 years old shows a correlation with Mix-type DED with OR 2.09 (p<0.05). Women have a higher predisposition to ADDE-type with OR 2.58 (p<0.05).

 

Conclusion: Moderate risk of OSA influences the occurrence of DED, both ADDE-type and Mix type; whereas high risk of OSA only correlates with ADDE-type. Older age plays a role in the occurrence of Mix-type DED and women have a higher tendency to present with ADDE- type.

Downloads

Download data is not yet available.

References

Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, et al. TFOS DEWS II definition and classification report. The ocular surface. 2017; 15(3):276-83.

Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Benítez-del-Castillo J, Boboridis KG, Merayo-Lloves J, Rolando M, Labetoulle M. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. British Journal of Ophthalmology. 2016 Mar 1;100(3):300-6.

Lee, A.J., Lee, J., Saw, S.M., Gazzard, G., Koh, D., Widjaja, D. and Tan, D.T.H., 2002. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. British Journal of Ophthalmology, 86(12), pp.1347-1351.

Abdal H, Pizzimenti JJ, Purvis CC. The eye in sleep apnea syndrome. Sleep medicine. 2006 Mar 1;7(2):107-15.

Mohamed EE, Massoud TH. Effect of sleep related breathing disorders on ocular function. Egyptian Journal of Chest Diseases and Tuberculosis. 2014 Jul 1;63(3):663- 9.

Karaca EE, Akçam HT, Uzun F, Özdek Ş, Çiftçi TU. Evaluation of ocular surface health in patients with obstructive sleep apnea syndrome. Turkish journal of ophthalmology. 2016 Jun;46(3):104.

Kuczyński, W.; Mokros, Ł.; Stolarz, A.; Białasiewicz, P. The Utility of STOP-BANG Questionnaire in the Sleep-Lab Setting. Sci. Rep. 2019, 9, 6676

Huon, L.-K.A.; Guilleminault, C. A Succinct History of Sleep Medicine. Adv. Otorhinolaryngol. 2017, 80, 1–6.

Schwartz, M.; Acosta, L.; Hung, Y.-L.; Padilla, M.; Enciso, R. Effects of CPAP and Mandibular Advancement Device Treatment in Obstructive Sleep Apnea Patients: A Systematic Review and Meta-Analysis. Sleep Breath. 2018, 22, 555–568

Khokhrina, A.; Andreeva, E.; Degryse, J.-M. The Prevalence of Sleep-Disordered Breathing in Northwest Russia: The ARKHsleep Study. Chron. Respir. Dis. 2020, 17, 147997312092810.

Saldías Peñafiel, F.; Brockmann Veloso, P.; Santín Martínez, J.; Fuentes-López, E.; Leiva Rodríguez, I.; Valdivia Cabrera, G. Estudio de prevalencia de síndrome de apneas obstructivas del sueño en la población adulta chilena. Subestudio de la Encuesta Nacional de Salud, 2016/17. Rev. Méd. Chile 2020, 148, 895–905.

Paduano, S.; Paduano, F.P.; Aiello, D.; Barbara, L.; Zampogna, S.; Pujia, R.; Malara, C.; Cantile, T.; Ferrazzano, G.F. OSAS in Developing Age: Screening of a Southern Italy Population. Eur. J. Paediatr. Dent. 2019, 20, 302–305.

Benjafield, A.V.; Ayas, N.T.; Eastwood, P.R.; Heinzer, R.; Ip, M.S.M.; Morrell, M.J.; Nunez, C.M.; Patel, S.R.; Penzel, T.; Pépin, J.-L.; et al. Estimation of the Global Prevalence and Burden of Obstructive Sleep Apnoea: A Literature-Based Analysis. Lancet Respir. Med. 2019, 7, 687–698.

Wang, S.; Niu, X.; Zhang, P.; Su, D.; Zhang, J.; Liu, W. Analysis of OSAS incidence and influential factors in middle-aged and elderly patients with hypertension. Minerva Med. 2019, 110, 115–120.

Peppard, P.E.; Young, T.; Barnet, J.H.; Palta, M.; Hagen, E.W.; Hla, K.M. Increased Prevalence of Sleep-Disordered Breathing in Adults. Am. J. Epidemiol. 2013, 177, 1006–1014.

Chen, L.; Pivetta, B.; Nagappa, M.; Saripella, A.; Islam, S.; Englesakis, M.; Chung, F. Validation of the STOP-Bang Questionnaire for Screening of Obstructive Sleep Apnea in the General Population and Commercial Drivers: A Systematic Review and Meta- Analysis. Sleep Breath. 2021, 1–11.

Stapleton F, Alves M, Bunya VY, et al. Tfos dews ii epidemiology report. Ocul Surf. 2017;15(3):334-365

Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86(12):1347- 1351.

Craig, J. P., Nichols, K. K., Akpek, E. K., Caffery, B., Dua, H. S., Joo, C. K., & Stapleton,

F. (2017). TFOS DEWS II definition and classification report. The ocular surface, 15(3), 276-283.

Institute of Medicine (US) Committee on Understanding the Biology of Sex and Gender Differences. Exploring the biological contributions to human health: does sex matter?. Washington, DC: The National Academies Press; 2001.

Bron AJ, dePaiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf 2017

Willcox MDP, Argüeso P, Georgiev G, Holopainen J, Laurie G, Millar T, et al. TFOS DEWS II tear film report. Ocul Surf 2017

Brignole F, Pisella P-J, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Investigative ophthalmology & visual science. 2000;41(6):1356-63.

Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Archives of ophthalmology. 2002;120(3):330-7.

Sammaritano M, Gigli GL, Gotman J. Interictal spiking during wakefulness and sleep and localization of foci in temporal lobe epilepsy. Neurology 1991;41:290.

Foulks, Gary N. "Pharmacological management of dry eye in the elderly patient." Drugs & aging 25.2 (2008): 105-118.

Pflugfelder, Stephen C., and Cintia S. de Paiva. "The pathophysiology of dry eye disease: what we know and future directions for research." Ophthalmology 124.11 (2017): S4-S13.

Dry Eye WorkShop. "Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop." Ocul Surf 5 (2007): 163-178.

Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Archives of ophthalmology. 2009 Jun 8;127(6):763-8.

Zhang Y, Chen H, Wu X. Prevalence and risk factors associated with dry eye syndrome among senior high school students in a county of Shandong Province, China. Ophthalmic epidemiology. 2012 Aug 1;19(4):226-30.

Uchino M, Nishiwaki Y, Michikawa T, Shirakawa K, Kuwahara E, Yamada M, Dogru M, Schaumberg DA, Kawakita T, Takebayashi T, Tsubota K. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology. 2011 Dec 1;118(12):2361-7.

Ahn JM, Lee SH, Rim TH, Park RJ, Yang HS, Im Kim T, Yoon KC, Seo KY, of the Korean ES, Society O. Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010–2011. American journal of ophthalmology. 2014 Dec 1;158(6):1205-14.

Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, Tan DT. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. British Journal of Ophthalmology. 2002 Dec 1;86(12):1347-51.

Shioka M, Shimmura S, Yagi Y, Tsubota K. Ptyerygium and dry eye. Ophthalmologica. 2001;215(3):209-11

Downloads

Published

2024-07-30

How to Cite

Aldina, R., Yanuar, F., Afif, Z., Holipah, & Prayitnaningsih, S. (2024). THE RELATIONSHIP BETWEEN RISKS OF OBSTRUCTIVE SLEEP APNEA AND DRY EYE DISEASE. MNJ (Malang Neurology Journal), 10(2), 194–199. https://doi.org/10.21776/ub.mnj.2024.010.02.21

Issue

Section

Research Article